Terms: = Ovarian cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Diagnosis
19 results:
1. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
[TBL] [Abstract] [Full Text] [Related]
2. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract] [Full Text] [Related]
3. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
[TBL] [Abstract] [Full Text] [Related]
4. Identification of novel prognosis-related genes in the endometrial cancer immune microenvironment.
Ma J; Zhang JK; Yang D; Ma XX
Aging (Albany NY); 2020 Nov; 12(21):22152-22173. PubMed ID: 33159014
[TBL] [Abstract] [Full Text] [Related]
5. Nuclear Atypia Is a Necessary Factor for diagnosis of Primary ovarian Fibrosarcoma: A Case Report and Literature Review.
Zhang Z; Yao A; Xin Q; Shi Y; Zhang A
Gynecol Obstet Invest; 2020; 85(5):437-445. PubMed ID: 33011729
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Significance of Annexin A4 as a Biomarker in the Early diagnosis of Hepatocellular Carcinoma.
Saad ZM; Fouad Y; Ali LH; Hassanin TM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
[TBL] [Abstract] [Full Text] [Related]
7. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
[TBL] [Abstract] [Full Text] [Related]
8. Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
Liang S; Tang W; Ye S; Xiang L; Wu X; Yang H
Thromb Res; 2020 Jun; 190():129-134. PubMed ID: 32361343
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study.
Stukan M; Badocha M; Ratajczak K
BMC Cancer; 2019 Jun; 19(1):564. PubMed ID: 31185938
[TBL] [Abstract] [Full Text] [Related]
10. Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up.
Horsboel TA; Kjaer SK; Johansen C; Suppli NP; Ammitzbøll G; Frøding LP; Lajer H; Dalton SO
Gynecol Oncol; 2019 Jun; 153(3):625-632. PubMed ID: 30975472
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic performance of CA 125, HE4, and risk of ovarian Malignancy Algorithm for ovarian cancer.
Kim B; Park Y; Kim B; Ahn HJ; Lee KA; Chung JE; Han SW
J Clin Lab Anal; 2019 Jan; 33(1):e22624. PubMed ID: 30009497
[TBL] [Abstract] [Full Text] [Related]
12. Prevalence and initial prescription of psychotropics in patients with common cancers in Japan, based on a nationwide health insurance claims database.
Sato I; Onishi H; Yamada S; Kawakami K
Psychooncology; 2018 Feb; 27(2):450-457. PubMed ID: 28750146
[TBL] [Abstract] [Full Text] [Related]
13. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
[TBL] [Abstract] [Full Text] [Related]
14. Rajavithi-ovarian cancer predictive score (R-OPS): A new scoring system for predicting ovarian malignancy in women presenting with a pelvic mass.
Yanaranop M; Tiyayon J; Siricharoenthai S; Nakrangsee S; Thinkhamrop B
Gynecol Oncol; 2016 Jun; 141(3):479-484. PubMed ID: 26996662
[TBL] [Abstract] [Full Text] [Related]
15. Factors associated with cancer-specific and overall survival among Indigenous and non-Indigenous gynecologic cancer patients in Queensland, Australia: a matched cohort study.
Diaz A; Moore SP; Martin JH; Green AC; Garvey G; Valery PC
Int J Gynecol Cancer; 2015 Mar; 25(3):542-7. PubMed ID: 25700033
[TBL] [Abstract] [Full Text] [Related]
16. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
[TBL] [Abstract] [Full Text] [Related]
17. The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer.
Zou L; He X; Zhang JW
Braz J Med Biol Res; 2010 Dec; 43(12):1232-8. PubMed ID: 21103788
[TBL] [Abstract] [Full Text] [Related]
18. Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior.
Ford ME; Havstad SL; Demers R; Cole Johnson C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):190-4. PubMed ID: 15668495
[TBL] [Abstract] [Full Text] [Related]
19. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study.
Olson JE; Cerhan JR; Janney CA; Anderson KE; Vachon CM; Sellers TA
Cancer; 2002 Mar; 94(5):1612-8. PubMed ID: 11920519
[TBL] [Abstract] [Full Text] [Related]
